🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
* Clinical trial phase: Phase 2 * Intervention model: Control group * Group...
Status
Recruiting
Location
NATIONAL CANCER CENTER 323, Ilsan-ro, Ilsandong-gu,
Start Date
2024-01-16
Trial ID
NCT06135896
Treatments Being Tested
This is an extension study for subjects who participated in Protocol 200900...
Status
Terminated
Location
Research Site
Start Date
2010-06-03
Trial ID
NCT01059448
Treatments Being Tested
Investigators will test the hypothesis that an increase in bone turnover ma...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2020-08-17
Trial ID
NCT04177940
Treatments Being Tested
This clinical trial will evaluate a new combination of pembrolizumab, HPV-1...
Status
Completed
Location
UPMC Hillman Cancer Center
Start Date
2020-07-06
Trial ID
NCT04369937
Treatments Being Tested
To determine the effect of denosumab treatment compared with placebo over 1...
Status
Completed
Location
Multiple Locations
Start Date
2002-05
Trial ID
NCT00043186
Treatments Being Tested
This is a Phase II, Randomized, Double-Blind, Placebo-Controlled, Multi-Cen...
Status
Terminated
Location
University of Miami Sylvester Comprehensive Cancer Center
Start Date
2017-05-14
Trial ID
NCT02737306
The purpose of this study was to compare the responses of 2 different doses...
Status
Completed
Location
City of Hope National Medical Center
Start Date
2010-10
Trial ID
NCT01164475
Treatments Being Tested
This is primarily an observational trial in patients with chronic anemia sy...
Status
Completed
Location
CHLA
Start Date
2018-07-15
Trial ID
NCT03715972
Treatments Being Tested
This phase I/II trial studies the effect of DS-1594b with or without azacit...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2021-03-25
Trial ID
NCT04752163
The purpose of this study is to compare 2 formulations of romosozumab (AMG ...
Status
Completed
Location
Research Site
Start Date
2013-12-03
Trial ID
NCT02016716
Treatments Being Tested